MedPath

WEST PENN ALLEGHENY HEALTH SYSTEM

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

19

Active:0
Completed:14

Trial Phases

3 Phases

Early Phase 1:1
Phase 4:6
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)β€’ Click on a phase to view related trials

Phase 4
6 (75.0%)
Early Phase 1
1 (12.5%)
Not Applicable
1 (12.5%)

The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling

Phase 4
Completed
Conditions
Stress Urinary Incontinence
Interventions
First Posted Date
2019-04-12
Last Posted Date
2025-10-03
Lead Sponsor
West Penn Allegheny Health System
Target Recruit Count
150
Registration Number
NCT03913845
Locations
πŸ‡ΊπŸ‡Έ

AHN Bethel Park Health + Wellness Pavilion, Bethel Park, Pennsylvania, United States

πŸ‡ΊπŸ‡Έ

AHN Jefferson Hospital, Jefferson Hills, Pennsylvania, United States

πŸ‡ΊπŸ‡Έ

AHN West Penn Hospital, Pittsburgh, Pennsylvania, United States

and more 1 locations

T-helper 2 (Th2) Cytokine Responses in Overweight/Obese Subjects

Completed
Conditions
Obesity
Overweight
First Posted Date
2014-03-13
Last Posted Date
2014-03-13
Lead Sponsor
West Penn Allegheny Health System
Target Recruit Count
46
Registration Number
NCT02085759
Locations
πŸ‡ΊπŸ‡Έ

Allegheny General Hospital, Dept. of Allergy, Asthma, & Immunology, Pittsburgh, Pennsylvania, United States

Comparing Sedara to Butorphanol in Early Labor

Not Applicable
Withdrawn
Conditions
Labor Pain
Interventions
Drug: 50% Nitrous Oxide/50% Oxygen
First Posted Date
2012-07-10
Last Posted Date
2020-10-05
Lead Sponsor
West Penn Allegheny Health System
Registration Number
NCT01636999
Locations
πŸ‡ΊπŸ‡Έ

West Penn Hospital, Pittsburgh, Pennsylvania, United States

Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis

Phase 4
Completed
Conditions
Asthma
Allergic Rhinitis
Interventions
Drug: Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo
Drug: Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase
Drug: QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo
Drug: QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris
Drug: Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase
Drug: Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
First Posted Date
2012-03-12
Last Posted Date
2020-11-04
Lead Sponsor
West Penn Allegheny Health System
Target Recruit Count
22
Registration Number
NCT01550471
Locations
πŸ‡ΊπŸ‡Έ

Pediatric Alliance-Greentree Division, Green Tree, Pennsylvania, United States

πŸ‡ΊπŸ‡Έ

Alleghney General Hospital, Pittsburgh, Pennsylvania, United States

Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth

Phase 4
Completed
Conditions
Asthma
Interventions
Drug: Beclomethasone, Budesonide, Fluticasone
Drug: Budesonide, Fluticasone, Beclomethasone
Drug: Fluticasone, Budesonide, Beclomethasone
Drug: Budesonide, Beclomethasone, Fluticasone
First Posted Date
2012-01-30
Last Posted Date
2020-11-18
Lead Sponsor
West Penn Allegheny Health System
Target Recruit Count
32
Registration Number
NCT01520688
Locations
πŸ‡ΊπŸ‡Έ

Pediatric Alliance-Greentree Division, Green Tree, Pennsylvania, United States

πŸ‡ΊπŸ‡Έ

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.